Dr. Kissaou Tchedre

Dr. Kissaou Tchedre | Director of Biopharmaceutical Operations

Dr. Kissaou Tchedre is Director of Biopharmaceutical Operations at Nanoscope, supporting our Development programs on Gene therapy from preclinical to clinical studies. He has management responsibilities for manufacturing and analytical operations. He is a Biomedical Scientist with decades of experience in commercial Occular Medical Device development at Menicon, a Japanese pharma/medical devices company. He got his MS in molecular biology and a PhD in Biomedical Sciences at the UNTHSC.

Dr. Tchedre did his post doc at Schepens Eye Research Institute at Harvard Medical School. He has international R&D and business experience in Japan, France and Switzerland.

Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186
  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Dr. Mohanty obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.